11/13/2024
3:05 PM | GYRE THERAPEUTICS, INC. (Filer)
Gyre Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/12/2024
7:45 PM | GYRE THERAPEUTICS, INC. (Filer)
Gyre Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/06/2024
7:31 AM | GYRE THERAPEUTICS, INC. (Subject)
Gyre Therapeutics (Subject)
Ma Songjiang (Filed by)
| Form SC 13D | |
09/06/2024
7:15 AM | GYRE THERAPEUTICS, INC. (Subject)
Gyre Therapeutics (Subject)
Luo Ying (Filed by)
| Form SC 13D | |
08/16/2024
8:13 PM | GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
Nussbaum Rodney L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/16/2024
7:53 PM | Chen Ruoyu (Reporting)
GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/16/2024
7:56 PM | GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
Luo Ying (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
08/16/2024
7:58 PM | Eastling Thomas Wilson (Reporting)
GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/16/2024
8:01 PM | GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
Ma Songjiang (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/16/2024
8:05 PM | Carmichael Gordon (Reporting)
GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/16/2024
8:07 PM | Epstein David M. (Reporting)
GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/16/2024
8:10 PM | GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
Parry Renate (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/16/2024
7:50 PM | GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
Ying Han (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/12/2024
8:04 PM | GYRE THERAPEUTICS, INC. (Filer)
Gyre Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2024
3:23 PM | Epstein David M. (Reporting)
GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
07/18/2024
3:31 PM | GYRE THERAPEUTICS, INC. (Subject)
Gyre Therapeutics (Subject)
USMAN NASSIM (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/17/2024
3:27 PM | GYRE THERAPEUTICS, INC. (Subject)
Gyre Therapeutics (Subject)
USMAN NASSIM (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/15/2024
4:19 PM | GYRE THERAPEUTICS, INC. (Subject)
Gyre Therapeutics (Subject)
USMAN NASSIM (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/12/2024
3:41 PM | GYRE THERAPEUTICS, INC. (Filer)
Gyre Therapeutics (Filer)
| Form RW | |
07/12/2024
3:42 PM | GYRE THERAPEUTICS, INC. (Filer)
Gyre Therapeutics (Filer)
| Form RW | |
07/05/2024
3:45 PM | GYRE THERAPEUTICS, INC. (Filer)
Gyre Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/05/2024
3:45 PM | GYRE THERAPEUTICS, INC. (Filer)
Gyre Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/03/2024
12:18 PM | GYRE THERAPEUTICS, INC. (Subject)
Gyre Therapeutics (Subject)
USMAN NASSIM (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/01/2024
4:56 PM | GYRE THERAPEUTICS, INC. (Subject)
Gyre Therapeutics (Subject)
USMAN NASSIM (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/01/2024
5:00 PM | GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
USMAN NASSIM (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/28/2024
4:19 PM | GYRE THERAPEUTICS, INC. (Subject)
Gyre Therapeutics (Subject)
USMAN NASSIM (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/17/2024
3:30 PM | GYRE THERAPEUTICS, INC. (Filer)
Gyre Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/08/2024
7:00 AM | GYRE THERAPEUTICS, INC. (Filer)
Gyre Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/02/2024
5:19 PM | GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
USMAN NASSIM (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/01/2024
3:51 PM | GYRE THERAPEUTICS, INC. (Subject)
Gyre Therapeutics (Subject)
USMAN NASSIM (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/29/2024
7:46 AM | GYRE THERAPEUTICS, INC. (Filer)
Gyre Therapeutics (Filer)
| Form DEF 14A | |
04/29/2024
7:48 AM | GYRE THERAPEUTICS, INC. (Filer)
Gyre Therapeutics (Filer)
| Form DEFA14A | |
04/29/2024
7:49 AM | GYRE THERAPEUTICS, INC. (Filer)
Gyre Therapeutics (Filer)
| Form ARS | |
04/09/2024
3:31 PM | GYRE THERAPEUTICS, INC. (Subject)
Gyre Therapeutics (Subject)
Wu Charles C (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/08/2024
5:03 PM | GYRE THERAPEUTICS, INC. (Subject)
Gyre Therapeutics (Subject)
Wu Charles C (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/05/2024
4:40 PM | GYRE THERAPEUTICS, INC. (Subject)
Gyre Therapeutics (Subject)
Wu Charles C (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/04/2024
4:27 PM | GYRE THERAPEUTICS, INC. (Subject)
Gyre Therapeutics (Subject)
Wu Charles C (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/02/2024
4:35 PM | GYRE THERAPEUTICS, INC. (Subject)
Gyre Therapeutics (Subject)
Wu Charles C (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/01/2024
5:42 PM | GYRE THERAPEUTICS, INC. (Subject)
Gyre Therapeutics (Subject)
USMAN NASSIM (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/27/2024
8:00 PM | GYRE THERAPEUTICS, INC. (Filer)
Gyre Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/27/2024
3:31 PM | GYRE THERAPEUTICS, INC. (Filer)
Gyre Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners (Ad) Trump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax Code…
And since then…
"In the know" patriots have quietly used this same "Trump revenge loophole" to shield their life savings from Bidenomics… Get Your Free Gold Guide |
03/27/2024
3:31 PM | GYRE THERAPEUTICS, INC. (Filer)
Gyre Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/26/2024
4:03 PM | GYRE THERAPEUTICS, INC. (Filer)
Gyre Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/25/2024
8:55 PM | GYRE THERAPEUTICS, INC. (Filer)
Gyre Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/21/2024
7:27 PM | GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
Nussbaum Rodney L (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
03/21/2024
7:31 PM | GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
Nussbaum Rodney L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2024
6:15 AM | GYRE THERAPEUTICS, INC. (Filer)
Gyre Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/15/2024
4:29 PM | GYRE THERAPEUTICS, INC. (Subject)
Gyre Therapeutics (Subject)
USMAN NASSIM (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/14/2024
4:16 PM | GYRE THERAPEUTICS, INC. (Filer)
Gyre Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
12:18 PM | GYRE THERAPEUTICS, INC. (Subject)
Gyre Therapeutics (Subject)
LYTTON LAURENCE W (Filed by)
| Form SC 13G/A | |
01/19/2024
3:05 PM | GYRE THERAPEUTICS, INC. (Filer)
Gyre Therapeutics (Filer)
| Form 8-K/A | |
01/12/2024
3:01 PM | GYRE THERAPEUTICS, INC. (Filer)
Gyre Therapeutics (Filer)
| Form 8-K/A | |
11/22/2023
6:55 PM | GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
Luo Ying (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2023
6:40 PM | GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
Ma Songjiang (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2023
6:49 PM | GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
Ye Weiguo (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2023
6:34 PM | Chen Ruoyu (Reporting)
GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2023
6:20 PM | GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
Wu Charles C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2023
6:27 PM | GNI Group Ltd. (Reporting)
GNI USA, Inc. (Reporting)
GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2023
6:06 PM | GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
Ma Songjiang (Reporting)
| Form 3/A | |
